These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24544200)

  • 1. [Chemotherapy and the tuberculosis bacillus].
    BOJALIL LF
    Rev Mex Tuberc Enferm Apar Respir; 1956; 17(1):19-24. PubMed ID: 24544200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Remarks on the streptomycin-resistance of Koch bacillus in pulmonary tuberculosis].
    HUTT JP; HERR RW
    Strasb Med; 1950 Dec; 1(12):667-73. PubMed ID: 14817601
    [No Abstract]   [Full Text] [Related]  

  • 3. [Streptomycin-resistance of Koch's bacillus in cavitary tuberculosis].
    CANETTI G; LACAZE H
    Rev Tuberc; 1950; 14(7-8):685-93. PubMed ID: 14787115
    [No Abstract]   [Full Text] [Related]  

  • 4. The fate of tubercle bacilli in vivo.
    HOBBY GL
    Am J Med; 1955 May; 18(5):753-63. PubMed ID: 14361459
    [No Abstract]   [Full Text] [Related]  

  • 5. The treated pulmonary lesion and its tubercle bacillus. II. The death and resurrection.
    VANDIVIERE HM; LORING WE; MELVIN I; WILLIS S
    Am J Med Sci; 1956 Jul; 232(1):30-7; passim. PubMed ID: 13326887
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance of Koch's bacillus to antibiotics and ambulatory treatment of pulmonary tuberculosis].
    JANJIC F
    Tuberkuloza; 1955; 7(4):245-55. PubMed ID: 13312093
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of the effect of conteben on the tubercle bacillus; the effect of conteben therapy upon the morphology and virulence of tubercle bacilli present in the sputum].
    BIENENGRABER A; URBACH H
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(1):68-82. PubMed ID: 14820743
    [No Abstract]   [Full Text] [Related]  

  • 8. [Resistance of Koch bacillus to paraaminosalicylic acid in cavernous pulmonary tuberculosis].
    VERAN P; RIST N; BALLET B; GRUMBACH F; TRICHEREAU R
    Rev Tuberc; 1951; 15(1-2):87-92. PubMed ID: 14876252
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of pulmonary tuberculosis with cyanacetic acid hydrazide and study of the resistance of Koch's bacillus to the principle antituberculosis drugs].
    TZELEPIDES P; KARADEMOS N; TZOUNRANES A; KOUPHONIKOLAS N; GOUNARES G
    Hell Iatr; 1961 Feb; 30():129-50. PubMed ID: 13778907
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bacteriostatic activity of 4-amino-5-iodosalicylic acid towards Koch's bacillus and first results in the treatment of pulmonary tuberculosis].
    PALERMO G
    Riforma Med; 1950 Dec; 64(49):1335-8. PubMed ID: 14809150
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of the Koch bacillus in isoniazide therapy; isoniazide-resistance and isoniazide-dependence].
    REALE M; GARAVENTA A; GHIONE M
    Minerva Med; 1952 Sep; 43(74):396-400. PubMed ID: 13012977
    [No Abstract]   [Full Text] [Related]  

  • 12. [Paraaminosalicylic acid in the TB. pulmonary].
    BARDESONO G
    Minerva Med; 1949 Jan; 40(5):131-3. PubMed ID: 18115408
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vivo relationship between 1314Th resistance and thiosemicarbazone resistance of tubercle bacilli in patients].
    TSUKAMURA M
    Kekkaku; 1962 Feb; 37():103-6. PubMed ID: 13922911
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies on the alpha-ethyl-thioisonicotinamide (1314Th) resistance of tubercle bacilli, with special regard to the resistance test by direct method and the mode of development of resistance].
    TSUKAMURA M; ABO T
    Kekkaku; 1961 Jun; 336():361-5. PubMed ID: 13778438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical study of the resistance of Koch's bacillus to antibiotics during pulmonary tuberculosis].
    DUBOIS-VERLIERE
    Sem Hop; 1954 Aug 10-14; 30(50-51):3006-8. PubMed ID: 13195754
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on problems of virulence and resistance of tubercle bacterial strains from pulmonary tuberculosis patients after chemotherapy].
    GIERHAKE FW
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 112(4):283-92. PubMed ID: 13219069
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the drug resistance of tubercle bacilli before and after chemotherapy of pulmonary tuberculosis].
    OKUBO H
    Kekkaku; 1961 Nov; 36():712-9. PubMed ID: 14481598
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental infective pneumoconiosis. V. Massive fibrosis of the lungs produced by coal-mine dust and Mycobacterium tuberculosis var. muris (Vole bacillus).
    KING EJ; YOGANATHAN M; HARRISON CV; MITCHISON DA
    AMA Arch Ind Health; 1957 Nov; 16(5):380-92. PubMed ID: 13468804
    [No Abstract]   [Full Text] [Related]  

  • 19. Catalase activity studies: a screening program for chemotherapy failures in tuberculosis treatment.
    SALIBA NA
    J Ky Med Assoc; 1959 Oct; 57():1196-9. PubMed ID: 14440999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relation between the virulence of Koch's bacillus and the clinical forms of pulmonary tuberculosis. II].
    BERGERON A; LAVAGNE-MEZIERE
    Rev Tuberc; 1950; 14(7-8):694-700. PubMed ID: 14787116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.